Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity: An analysis of 92 cases

Cancer

Volumn 98, Issue 4, 2003, Pages 805-813

  Deyrup, Andrea T ^a   Haydon, Rex C ^a   Huo, Dezheng ^b   Ishikawa, Akira ^a,c   Peabody, Terrance D ^a   He, Tong Chuan ^a   Montag, Anthony G ^a,c  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

Immunohistochemistry; Malignant fibrous histiocytoma (MFH); Myogenic; Myoid; Prognosis; Sarcoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SIZE; FEMALE; FIBROSARCOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOSARCOMA; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; NERVE SHEATH TUMOR; PLEOMORPHIC SARCOMA; PRIORITY JOURNAL; PROGNOSIS; SARCOMA; SPINDLE CELL SARCOMA; SYNOVIAL SARCOMA; TUMOR LOCALIZATION;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; DESMIN; EXTREMITIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE PROTEINS; MYOGLOBIN; PROGNOSIS; SARCOMA; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0042572472     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11617     Document Type: Article

References (27)

1. Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue pathology, 4th edition. St. Louis: Mosby, 2001.
2. Beahrs OH, Henson DE, Hutter RVP, et al., editors. Manual for staging of cancer, 3rd edition. Philadelphia: Lippincott, 1992.
3. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1980;153:106.
4. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
5. Cox D. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187-220.
6. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
7. O'Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer Metastasis Rev. 1964;17:1445-1456.
8. Schurch W, Begin LR, Seemayer TA, et al. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s. Am J Surg Pathol. 1996;20:131-147.
9. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer. 1978;41:2250-2266.
10. Weiss SW. Malignant fibrous histiocytoma. A reaffirmation. Am J Surg Pathol. 1982;6:773-784.
11. Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma [see comments]. Am J Surg Pathol. 1992;16:213-228. Comments in: Am J Surg Pathol. 1992;16:1023-1024; Am J Surg Pathol. 1993;17:422-423.
12. Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma [see comments]. Am J Surg Pathol. 1992;16:213-228. Comments in: Am J Surg Pathol. 1992;16:1023-1024; Am J Surg Pathol. 1993;17:422-423.
13. Fletcher CD, Gustafson P, Rydholm A, Willen H, Akerman M. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol. 2001;19:3045-3050.
14. Hashimoto H, Daimaru Y, Takeshita S, Tsuneyoshi M, Enjoji M. Prognostic significance of histologic parameters of soft tissue sarcomas. Cancer. 1992;70:2816-2822.
15. Coindre JM, Terrier P, Guillou L, et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer. 2001;91:1914-1926.
16. Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol. 1996;14:1679-1689.
17. Chen CM, Chen CJ, Chang CL, Shyu JS, Hsieh HF, Harn HJ. CD34, CD117, and actin expression in phyllodes tumor of the breast. J Surg Res. 2000;94:84-91.
18. Banerjee SS, Bishop PW, Nicholson CM, Eyden BP. Malignant melanoma showing smooth muscle differentiation. J Clin Pathol. 1996;49:950-951.
19. Banerjee S, Agbamu D, Eyden B, Harris M. Clinicopathological characteristics of peripheral primitive neuroectodermal tumour of skin and subcutaneous tissue. Histopathology. 1997;31:355-366.
20. Gebhard S, Coindre JM, Michels JJ, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2002;26:601-616.
21. Gibas Z, Miettinen M, Limon J, et al. Cytogenetic and immunohistochemical profile of myxoid liposarcoma. Am J Clin Pathol. 1995;103:20-26.
22. Oda Y, Miyajima K, Kawaguchi K, et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma [see comment]. Am J Surg Pathol. 2001;25:1030-1038. Comment in: Am J Surg Pathol. 2002;26:393-394; discussion 394-396.
23. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol. 2001;14:595-603.
24. Hasegawa T, Yamamoto S, Nojima T, et al. Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol. 2002;33:111-115.
25. Singer S, Corson JM, Gonin R, Labow B, Eberlein TJ. Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma [see comment]. Ann Surg. 1994;219:165-173. Comment in: Ann Surg. 1995; 221:203-205.
26. Bieche I, Lazar V, Nogues C, et al. Prognostic value of chorionic gonadotropin beta gene transcripts in human breast carcinoma. Clin Cancer Res. 1998;4:671-676.
27. Mertens F, Stromberg U, Mandahl N, et al. Prognostically important chromosomal aberrations in soft tissue sarcomas: a report of the Chromosomes and Morphology (CHAMP) Study Group. Cancer Res. 2002;62:3980-3984.